Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

May 16, 2019 11:26 UTC

$2.7 Bn NGS Sample Preparation Market, 2024 by Product, Workflow, Application, & Technology - ResearchAndMarkets.com

DUBLIN--(Business Wire)--The "NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 18.7% during the forecast period.

The growth of this market is driven by increasing application of NGS in diagnostics and genomics research, increasing adoption of NGS for diagnostics (due to the decreasing cost of NGS products and services), and development of low-cost sequencing technologies are expected to drive the market growth in the future.

The library preparation products segment to register the highest CAGR in the NGS reagents and consumables market.

Based on workflow, the reagents & consumables segment is subsegmented into library preparation, target enrichment, and quality control. Library preparation segment is classified into DNA (Human WGS, targeted sequencing, whole exome sequencing, and others) and RNA (gene expression analysis, whole transcriptome, and others) on the basis of type.

In 2018, the library preparation segment accounted for the largest share of the NGS reagents and consumables market. Advancements in the NGS protocols for library preparation and the increasing number of research activities are driving the growth of the library preparation market.

The academic institutes & research centers segment is expected to dominate the end-user segment.

Based on end user, the NGS sample preparation market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The academic institutes & research centers segment is expected to account for the largest share the NGS sample preparation market during the forecast period.

The increasing number of collaborations between NGS market players and academic & research institutions; availability of financial support for genomics R&D across regions; and the development of cost-effective NGS products and services for researchers are the major factors supporting the growth of this end-user segment.

The NGS sample preparation market in the APAC is projected to grow at the highest rate during the forecast period.

The Asia Pacific NGS sample preparation market is expected to witness the highest CAGR from 2019 to 2024. Increasing financial support from public as well as private agencies, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in key APAC countries are the major factors driving the growth of this regional market.

Several companies such as Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), and Beckman Coulter (a subsidiary of Danaher), among others, are investing in high-growth markets to gain significant profits and increase their share in the NGS sample preparation market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 NGS Sample Preparation: Market Overview

4.2 NGS Sample Preparation Market Share, By Product, 2018

4.3 Market, By End User, 2019 vs. 2024 (USD Million)

4.4 Market, By Application, 2019 vs. 2024 (USD Million)

4.5 Market, By Region

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Advancements in NGS Platforms

5.2.1.2 Declining Cost of Sequencing

5.2.1.3 Improving Reimbursement Scenario for NGS-Based Diagnostic Tests

5.2.2 Restraints

5.2.2.1 End User Budget Constraints in Developing Countries

5.2.3 Opportunities

5.2.3.1 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects

5.2.3.2 Increasing Applications of NGS

5.2.4 Challenges

5.2.4.1 Ethical Issues

6 NGS Sample Preparation Market, By Product

6.1 Introduction

6.2 Reagents & Consumables

6.2.1 Rising Adoption of NGS is Supporting the Use of NGS Reagents and Consumables

6.3 NGS Workstations

6.3.1 High Throughput and Reduction in Hands-On Time Ensures the Adoption of Workstations in NGS Workflow

7 NGS Reagents and Consumables Market, By Workflow

7.1 Introduction

7.2 Library Preparation

7.2.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection

7.2.1.1 Availability of Products From Various Players Drives the Market for This Segment

7.2.2 DNA Library Preparation

7.2.2.1 Whole Exome Sequencing

7.2.2.2 Targeted Sequencing

7.2.2.3 Whole Genome Sequencing

7.2.2.4 Others

7.2.3 RNA Library Preparation

7.2.3.1 Gene Expression Analysis

7.2.3.2 Whole Transcriptome Sequencing

7.2.3.3 Other RNA Applications

7.3 Target Enrichment

7.3.1 Targeted Sequencing

7.3.2 Whole Exome Sequencing

7.3.3 Others

7.4 Quality Control

7.4.1 Importance of Quality Control Step in the NGS Workflow & Rising Number of Research Activities Using NGS Technology are the Key Factors Driving Market Growth

8 NGS Library Preparation & Target Enrichment Market, By Technology

8.1 Introduction

8.2 Sequencing By Synthesis (Sbs)

8.2.1 Sbs has A Wide Customer Base Owing to Its Well-Established Precision in Sequencing as Well as Its Broad Application Base

8.3 Ion Semiconductor Sequencing

8.3.1 Extensive Applications of Ion Semiconductor Sequencing to Drive Market Growth

8.4 Single-Molecule Real-Time Sequencing (Smrt)

8.4.1 High Cost of Smrt-Based Platforms to Restrain Market Growth

8.5 Nanopore Sequencing

8.5.1 Small Size and Low Equipment Costs to Support the Adoption of Nanopore Sequencing Platforms By Various End Users

8.6 Other Sequencing Technologies

9 NGS Sample Preparation Market, By Application

9.1 Introduction

9.2 Diagnostics

9.2.1 Cancer Diagnostics

9.2.1.1 Increasing Cancer Patient Population Across the Globe is Driving This Segment

9.2.2 Infectious Disease Diagnostics

9.2.3 Reproductive Health Diagnostics

9.2.4 Other Disease Diagnostic Applications

9.3 Drug Discovery

9.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery and Development to Drive the Adoption NGS Sample Preparation Products

9.4 Agricultural & Animal Research

9.4.1 Funding & Support for Animal and Plant Genomics Research to Support the Adoption of NGS Sample Preparation Products

9.5 Other Applications

10 NGS Sample Preparation Market, By End User

10.1 Introduction

10.2 Academic Institutes & Research Centers

10.2.1 Availability of Financial Support for Genomics Research to Support the Growth of This Segment

10.3 Hospitals & Clinics

10.3.1 NGS Technology to Witness Significant Adoption in Disease Diagnosis Owing to Its Advantages Over Conventional Methods

10.4 Pharmaceutical & Biotechnology Companies

10.4.1 Continuous Focus of Pharmaceutical and Biotechnology Companies on Targeted therapies for Precision Medicine to Drive the Growth of ThisEnd-User Segment

10.5 Other End Users

11 NGS Sample Preparation Market, By Region

11.1 Introduction

11.2 North America

11.3 US

11.3.1 Favorable Regulatory and Reimbursement Scenario for NGS-Based Diagnostics Tests in the Country Drives the Market

11.4 Canada

11.4.1 Favorable Government Funding Scenario in Canada Boost Genomics Research

11.5 Europe

11.6 Germany

11.6.1 Strong R&D Base in Germany Supports Market Growth

11.7 UK

11.7.1 Use of NGS-Based Test for Disease Diagnosis Will Drive Market Growth

11.8 France

11.8.1 Support for Genomics Research is A Key Driver of Market Growth

11.8.2 RoE

11.9 Asia Pacific

11.9.1 China

11.9.2 Japan

11.9.3 India

11.9.4 Rest of Asia Pacific

11.10 Rest of the World

12 Competitive Landscape

12.1 Overview

12.2 Market Share Analysis, 2018

12.3 Competitive Scenario

12.4 Vendor Inclusion Criteria

12.5 Competitive Leadership Mapping (Overall Market - 2017)

13 Company Profile

13.1 Agilent Technologies, Inc.

13.2 Becton, Dickinson and Company

13.3 Beckman Coulter (A Subsidiary of Danaher)

13.4 F. Hoffmann-La Roche AG

13.5 Illumina, Inc.

13.6 New England Biolabs, Inc.

13.7 Nugen Technologies, Inc. (Part of Tecan Trading Ag)

13.8 Oxford Gene Technology (Part of Sysmex)

13.9 Oxford Nanopore Technologies, Ltd.

13.10 Pacific Biosciences of California, Inc.

13.11 Perkinelmer, Inc.

13.12 QIAGEN N.V.

13.13 Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)

13.14 Swift Biosciences Inc.

13.15 Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2wdyfa

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Laboratory Testing, Molecular Diagnostics

Latest News
Top News